Hannover Marketing und Tourismus GmbH (HMTG)
Ergebnis der Suchanfrage nach Celle
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- 2mehr
- 4
Shaping the sustainable fibre future with cellulose fibres – Abstract submissions open for the Cellulose Fibres Conference 2024
Ein Dokumentmehr Technische Universität München
Robotics: New skin-like sensors fit almost everywhere
TECHNICAL UNIVERSITY OF MUNICH PRESS RELEASE Automated production for different objects Robotics: New skin-like sensors fit almost everywhere - New approach makes it possible to equip objects of arbitrary shapes with smart sensors. - Innovative soft sensors are intended for use in robotics and especially in prosthetics. - Researchers see major advantages in the seamless and customizable sensor technology versus existing ...
mehrTechnische Universität München
4D printing for nerve stimulation: Self-folding electrodes stimulate fine nerves
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE Self-folding electrodes stimulate fine nerves 4D printing for nerve stimulation - Researchers have produced very fine, flexible electrodes - Upon contact with tissue moisture, the electrodes wrap themselves around thin nerves - Nerve stimulation and recording with the foldable electrodes has already been demonstrated in ...
mehrWildDISCO: Visualizing Whole Bodies in Unprecedented Detail
mehrLAMILUX Composites Establishment of the new division "Business Unit Building and Construction"
Ein DokumentmehrAnother step towards electrified aviation: CustomCells enters cooperation with VÆRIDION
mehr- 2
Brand new: Six new online presentations on GRP
Ein Dokumentmehr Potentiating Cancer Vulnerability to Ferroptosis: Off-Targeting Effects of DHODH Inhibitors
mehr- 2
CARAMBA: New Hope for Multiple Myeloma Patients
mehr New Approach in Cancer Therapy With Innovative Mechanism-of-Action for Ferroptosis Induction
mehrPM: Bessere Logistik für eine bessere Gesundheitsversorgung: DHL-Whitepaper identifiziert Trends, Änderungen und Lösungen im Supply-Chain-Management des Life-Sciences- und Healthcare-Sektors / PR: Advancing healthcare delivery: DHL white paper identi
mehrRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected
mehrLAMILUX Composites at Caravan Salon 2023, Hall 13 Stand A85
Ein DokumentmehrLONGi Green Energy Technology Co., Ltd.
33.5% - LONGi announces new conversion efficiency for its silicon-perovskite tandem solar cells at Intersolar Europe 2023
Munich (ots) - LONGi Green Energy Technology Co., Ltd. announced its most recent achievement of a new 33.5% efficiency for its perovskite-crystalline silicon tandem solar cells based on commercial CZ silicon wafers at the world's leading trade fair for the solar industry, the Intersolar 2023. According to the ...
mehrCustomcells launches development partnership with OneD
mehrLONGi Green Energy Technology Co., Ltd.
LONGi Solar and Energy3000 sign 1.5 GW supply framework agreement
mehrLONGi Green Energy Technology Co., Ltd.
LONGi presents “STAR Innovative Ecological Collaboration Platform” at Intersolar 2023 to build global ecosystem for PV innovation
Munich (ots) - Today, LONGi Green Energy Technology Co., Ltd. debuted its “STAR Innovative Ecological Cooperation Platform” in Europe during this year’s Intersolar exhibition in Munich, Germany. The global platform will focus on the development of PV innovation technology and serve as an enabler for building a ...
mehrEA Elektro-Automatik GmbH & Co. KG
EA Elektro-Automatik announces High-Power, High-Efficiency Triple Output Battery Testing Devices / Test, simulate, and recycle battery packs with voltages up to 920 V and power capacity to 30 kW
mehrGeneverse Empowers a Whole New Market with Debut and Product Launch at Intersolar Europe with the Introduction of the First Complete Home Solar Energy System for Every Home in the EU
San Francisco, CA (ots) - Geneverse, a US-based provider of innovative home solar power solutions, is excited to announce its debut in the EU market at the highly anticipated Intersolar Europe exhibition, held as part of The Smarter E Show. The event, taking place in Munich, Germany in June, will showcase ...
mehrSunlight Group Energy Storage Systems
Sunlight Group to present its latest lithium-based Energy Storage solutions at "The smarter E Europe" international exhibition
mehrFirst Integrated Single-Cell Atlas of the Human Lung
Can a human organ be mapped on a single-cell level to learn about the functionality of each individual cell? And can we learn how different these cells are from person to person? Helmholtz Munich researchers and their collaborators have taken up this challenge and developed the Human Lung Cell Atlas using artificial intelligence (AI)-based techniques. This atlas elucidates the diversity of single lung cell types and ...
mehrFrench Innovation shines at Intersolar 2023
mehrDEBIOPHARM LAUNCHES PHASE 1 RESEARCH IN SMALL CELL LUNG CANCER WITH WEE1 INHIBITOR DEBIO 0123 TO OUTSMART DDR IN SMALL CELL LUNG CANCER
Lausanne, Switzerland (ots) - - Debiopharm combines its potent WEE1-inhibitor Debio 0123 with standard-of-care therapy to short-circuit DNA damage repair (DDR) in adults with recurrent or progressive small cell lung cancer (SCLC). - The first patient dosed at Vall d’Hebron Hospital (Barcelona, Spain), was ...
mehrHubble Lithium, the #1 Energy Storage Solutions provider in South Africa, set their sites on global expansion at The Smarter E 2023
mehrLAMILUX Composites joins the Bavarian Environmental and Climate Pact
Ein DokumentmehrBirth weight and head circumference predict IQ and motor performance at 4 years of age
mehr- 2
LAMILUX SUNSATION® wins German Innovation Award
Ein Dokumentmehr - 3
PR: LAMILUX Composites innovations at transport logistic
Ein Dokumentmehr DEBIOPHARM LAUNCHES PHASE 1/2 COMBINATION TRIAL INVESTIGATING BRAIN-PENETRANT SELECTIVE WEE1 INHIBITOR FOR BRAIN CANCER PATIENTS
Lausanne (ots) - - Glioblastomas (GBM) are among the most aggressive and lethal tumors of the central nervous system with a 5-year survival rate of only 6.8%. - Debiopharm is combining its potent, brain penetrant WEE1 inhibitor Debio 0123 with standard of care (SOC) therapy. Debio 0123 hopes to hinder DNA damage ...
mehr